Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12415487 | 0.79 | ALDH1A1 (0.37) | ALDH1A1POLBPKMCTDSP1TDP1 | |
| SCHEMBL12415479 | 0.79 | ALDH1A1 (0.36) | ALDH1A1POLBPKMCTDSP1TDP1 | |
| SCHEMBL12415484 | 0.76 | SMN1; SMN2 (0.49) | ALDH1A1 | |
| SCHEMBL12415507 | 0.76 | ALDH1A1 (0.35) | ALDH1A1PKMCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL12415489 | 0.75 | CNR2 (0.48) | ALDH1A1 | |
| SCHEMBL18098028 | 0.74 | ALDH1A1 (0.33) | ALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL12415494 | 0.72 | ALDH1A1 (0.36) | ALDH1A1POLBPKMCTDSP1TDP1 | |
| SCHEMBL15369556 | 0.72 | LMNA (0.30) | — | |
| SCHEMBL20313806 | 0.71 | ALDH1A1 (0.35) | ALDH1A1POLBPKMMAPTCYP1A2 | |
| SCHEMBL12415486 | 0.71 | PIK3CD (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140080984-A1 | HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS | ZANNA SCITECH CO., LTD. (CN) | 2014-03-20 | — | — | US | disclosed |
| US-20110172381-A1 | HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS | ZANNA SCITECH CO., LTD. (CN) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172381-A1 | HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS | RCSD1, RRP12, TIAM1 | ALDH1A1 3240/4885POLB 1605/4885PKM 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.